Authors:
MERLE PA
THEIJSMEIJER P
JANSSEN JJWM
OSSENKOPPELE GJ
VANOOSTVEEN JW
Citation: Pa. Merle et al., MULTIPLEX RT-PCR DOES NOT DISTINGUISH BETWEEN A BCR-ABL TRANSCRIPT LACKING ABL EXON A2 (ALL) AND B2A2 TRANSCRIPTS (CML), British Journal of Haematology, 102(1), 1998, pp. 110-110
Authors:
VERVOORDELDONK SF
MERLE PA
BEHRENDT H
STEENBERGEN EJ
VANDENBERG H
VANWERING ER
VONDEMBORNE AEGK
VANDERSCHOOT CE
VANLEEUWEN EF
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PCR-POSITIVITY IN HARVESTED BONE-MARROW PREDICTS RELAPSE AFTER TRANSPLANTATION WITH AUTOLOGOUS PURGED BONE-MARROW IN CHILDREN IN 2ND REMISSION OF PRECURSOR B-CELL ACUTE-LEUKEMIA, British Journal of Haematology, 96(2), 1997, pp. 395-402
Authors:
VERVOORDELDONK SF
HEIKENS J
GOEDEMANS WT
MERLE PA
VONDEMBORNE AEGK
VANROYEN EA
SLAPERCORTENBACH ICM
VANOERS RHJ
Citation: Sf. Vervoordeldonk et al., TC-99M-CD19 MONOCLONAL-ANTIBODY IS NOT USEFUL FOR IMAGING OF B-CELL NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 42(5), 1996, pp. 291-296
Authors:
VERVOORDELDONK SF
MERLE PA
BEHRENDT H
STEENBERGEN EJ
VANLEEUWEN EF
VANDENBERG H
VONDEMBORNE AEGK
VANDERSCHOOT CE
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR PREDICTION OF RELAPSE IN CHILDHOOD PRECURSOR-B ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 92(4), 1996, pp. 922-928
Authors:
STEENBERGEN EJ
VERHAGEN OJHM
VANLEEUWEN EF
BEHRENDT H
MERLE PA
WESTER MR
VONDEMBORNE AEGK
VANDERSCHOOT CE
Citation: Ej. Steenbergen et al., B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA 3RD COMPLEMENTARITY-DETERMINING REGIONS PREDOMINANTLY REPRESENT AN UNBIASED RECOMBINATION REPERTOIRE - LEUKEMIC TRANSFORMATION FREQUENTLY OCCURS IN FETAL LIFE, European Journal of Immunology, 24(4), 1994, pp. 900-908
Authors:
VERVOORDELDONK SF
MERLE PA
VANLEEUWEN EF
VONDEMBORNE AEGK
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PRECLINICAL STUDIES WITH RADIOLABELED MONOCLONAL-ANTIBODIES FOR TREATMENT OF PATIENTS WITH B-CELL MALIGNANCIES, Cancer, 73(3), 1994, pp. 1006-1011
Authors:
VERVOORDELDONK SF
MERLE PA
VANLEEUWEN EF
VANDERSCHOOT CE
VONDEMBORNE AEGK
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., FC-GAMMA RECEPTOR-II (CD32) ON MALIGNANT B-CELLS INFLUENCES MODULATION INDUCED BY ANTI-CD19 MONOCLONAL-ANTIBODY, Blood, 83(6), 1994, pp. 1632-1639
Authors:
VERVOORDELDONK SF
MERLE PA
VANLEEUWEN EF
VANDERSCHOOT CE
VONDEMBORNE AEGK
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., THE INFLUENCE OF FC-GAMMA-RECEPTOR EXPRESSION ON MALIGNANT B-CELLS ONANTIGEN MODULATION IN MONOCLONAL-ANTIBODY THERAPY, Experimental hematology, 21(8), 1993, pp. 1116-1116
Authors:
VERVOORDELDONK SF
MERLE PA
VANLEEUWEN EF
VANDERSCHOOT CE
VONDEMBORNE AEGK
SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 82(10), 1993, pp. 10000551-10000551